SEARCH

SEARCH BY CITATION

References

  • Adderley SR and Fitzgerald DJ (1999) Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem, 274, 50385046.
  • Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW and Jacks T (2000) PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev, 14, 704718.
  • Band V, Zajchowski D, Swisshelm K, Trask D, Kulesa V, Cohen C, Connolly J and Sager R (1990) Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res, 50, 73517357.
  • Bates SE, Valverius EM, Ennis BW, Bronzert DA, Sheridan JP, Stampfer MR, Mendelsohn J, Lippman ME and Dickson RB (1990) Expression of the transforming growth factor-α/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinology, 126, 596607.
  • Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature, 377, 646649.
  • Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science, 282, 14971501.
  • Chan TA, Morin PJ, Vogelstein B and Kinzler KW (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA, 95, 681686.
  • Chang YW, Jakobi R, McGinty A, Foschi M, Dunn MJ and Sorokin A (2000) Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity. Mol Cell Biol, 20, 85718579.
  • Chen QR, Miyaura C, Higashi S, Murakami M, Kudo I, Saito S, Hiraide T, Shibasaki Y and Suda T (1997) Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1. J Biol Chem, 272, 59525958.
  • Dowd NP, Scully M, Adderley SR, Cunningham AJ and Fitzgerald DJ (2001) Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo. J Clin Invest, 108, 585590.
  • DuBois RN, Awad J, Morrow J, Roberts LJ,2nd and Bishop PR (1994) Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J Clin Invest, 93, 493498.
  • El-Deiry WS et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817825.
  • Fang L, Li G, Liu G, Lee SW and Aaronson SA (2001) p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J, 20, 19311939.
  • Feng L, Xia Y, Garcia GE, Hwang D and Wilson CB (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α and lipopolysaccharide. J Clin Invest, 95, 16691675.
  • Geba GP, Weaver AL, Polis AB, Dixon ME and Schnitzer TJ (2002) Efficacy of rofecoxib, celecoxib and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA, 287, 6471.
  • Grosch S, Tegeder I, Niederberger E, Brautigam L and Geisslinger G (2001) COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J, 15, 27422744.
  • Gunn JM, Bodner JB, Knowles SE and Ballard FJ (1983) Inhibition of protein breakdown by epidermal growth factor in IMR90 human fibroblasts and other mammalian cell lines. Biochem J, 210, 251258.
  • Hansen-Petrik MB, McEntee MF, Jull B, Shi H, Zemel MB and Whelan J (2002) Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice. Cancer Res, 62, 403408.
  • Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T, Sugiura T, Ogawa M and Takahashi T (2000) Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res, 6, 20062011.
  • Howell G et al. (1998) Regulation of transforming growth factor α expression in a growth factor-independent cell line. Mol Cell Biol, 18, 303313.
  • Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM and Chen CS (2000) The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem, 275, 1139711403.
  • Ji Q-s, Ermini S, Baulida J, Sun F-l and Carpenter G (1998) Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts. Mol Biol Cell, 9, 749757.
  • Kawamori T, Rao CV, Seibert K and Reddy BS (1998) Chemo preventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res, 58, 409412.
  • Kirtikara K, Morham SG, Raghow R, Laulederkind SJ, Kanekura T, Goorha S and Ballou LR (1998) Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells. J Exp Med, 187, 517523.
  • Ledwith BJ, Pauley CJ, Wagner LK, Rokos CL, Alberts DW and Manam S (1997) Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promoters in immortalized mouse liver cells. J Biol Chem, 272, 37073714.
  • Lee SW, Fang L, Igarashi M, Ouchi T, Lu KP and Aaronson SA (2000) Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc Natl Acad Sci USA, 97, 83028305.
  • Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323331.
  • Lin MT, Lee RC, Yang PC, Ho FM and Kuo ML (2001) Cyclooxygenase-2 inducing a Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells: involvement of PI 3-K/Akt pathway. J Biol Chem, 276, 4899749002.
  • Lin Y, Ma W and Benchimol S (2000) Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat Genet, 26, 122127.
  • McClelland RA, Barrow D, Madden TA, Dutkowski CM, Pamment J, Knowlden JM, Gee JM and Nicholson RI (2001) Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex). Endocrinology, 142, 27762788.
  • McGinty A, Chang YW, Sorokin A, Bokemeyer D and Dunn MJ (2000) Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells. J Biol Chem, 275, 1209512101.
  • Misko TP, Trotter JL and Cross AH (1995) Mediation of inflammation by encephalitogenic cells: interferon γ induction of nitric oxide synthase and cyclooxygenase 2. J Neuroimmunol, 61, 195204.
  • Miyashita T and Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293299.
  • Modjtahedi H, Komurasaki T, Toyoda H and Dean C (1998) Anti-EGFR monoclonal antibodies which act as EGF, TGFα, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours. Int J Cancer, 75, 310316.
  • Morham SG et al. (1995) Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell, 83, 473482.
  • Nakano K and Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell, 7, 683694.
  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science, 288, 10531058.
  • Perkins DJ and Kniss DA (1997) Rapid and transient induction of cyclo-oxygenase 2 by epidermal growth factor in human amnion-derived WISH cells. Biochem J, 321, 677681.
  • Phillips RK et al. (2002) A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut, 50, 857860.
  • Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B (1997) A model for p53-induced apoptosis. Nature, 389, 300305.
  • Russell KS, Stern DF, Polverini PJ and Bender JR (1999) Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis. Am J Physiol, 277, H2205H2211.
  • Sawhney RS, Zhou GK, Humphrey LE, Ghosh P, Kreisberg JI and Brattain MG (2002) Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands. J Biol Chem, 277, 7586.
  • Sheng H, Williams CS, Shao J, Liang P, DuBois RN and Beauchamp RD (1998a) Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J Biol Chem, 273, 2212022127.
  • Sheng H, Shao J, Morrow JD, Beauchamp RD and DuBois RN (1998b) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res, 58, 362366.
  • Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A and Bolli R (2000) Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA, 97, 1019710202.
  • Smith WL, Garavito M and DeWitt DL (1996) Prostaglandin endoperoxide synthase (cyclooxygenase)-1 and -2. J Biol Chem, 271, 3315733160.
  • Steinauer KK, Gibbs I, Ning S, French JN, Armstrong J and Knox SJ (2000) Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells. Int J Radiat Oncol Biol Phys, 48, 325328.
  • Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A and Dannenberg AJ (1999) Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem, 274, 1091110915.
  • Subbaramaiah K, Hart JC, Norton L and Dannenberg AJ (2000) Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 and p38 mitogen-activated protein kinase pathways. J Biol Chem, 275, 1483814845.
  • Sugrue MM, Shin DY, Lee SW and Aaronson SA (1997) Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci USA, 94, 96489653.
  • Thomas D and Bradshaw RA (1997) Differential utilization of ShcA tyrosine residues and functional domains in the transduction of epidermal growth factor-induced mitogen-activated protein kinase activation in 293T cells and nerve growth factor-induced neurite outgrowth in PC12 cells. J Biol Chem, 272, 2229322299.
  • Trifan OC, Smith RM, Thompson BD and Hla T (1999) Over expression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. J Biol Chem, 274, 3414134147.
  • Tsujii M and DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493501.
  • Van Putten V, Refaat Z, Dessev C, Blaine S, Wick M, Butterfield L, Han SY, Heasley LE and Nemenoff RA (2001) Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. J Biol Chem, 276, 12261232.
  • Vogelstein B, Lane D and Levine AJ (2000) Surfing the p53 network. Nature, 408, 307310.
  • Vousden KH (2000) p53: death star. Cell, 103, 691694.
  • Wu GS et al. (1997) KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nature Genet, 17, 141143.
  • Xie W and Herschman HR (1995) v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor. J Biol Chem, 270, 2762227628.
  • Yang A and McKeon F (2000) P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol, 1, 199207.
  • Yang T, Huang Y, Heasley LE, Berl T, Schnermann JB and Briggs JP (2000) MAPK mediation of hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary collecting duct cells. J Biol Chem, 275, 2328123286.
  • Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell, 7, 673682.
  • Zahner G, Wolf G, Ayoub M, Reinking R, Panzer U, Shankland SJ and Stahl RA (2002) Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor induced mesangial cell proliferation through induction of the tumor suppressor p53 and the cyclin dependent kinase inhibitors p21cip1 and p27kip1. J Biol Chem, 277, 97639771.